COVID-19: China Healthcare Implications for Private Equity Investors

Stephen Sunderland

china healthcare implications

drive practical insight

economic activity index

healthcare opening

corporate data

proprietary survey

trajectory survey

important pivots

pivots impact

AI broadly utilized

robotic industry

telehealth impact

remote solutions

financial pain

self succiency

supply chain disruptive

positive views

innovative biopharma

parallel innovation

cell therapy

temporary growth

medtech market

faster recovery

china changed landscape

global investors

connect

disclaimer

Related Insights

Life Sciences & Pharma

COVID-19

COVID-19 Implications for Asia-Pacific Healthcare Ecosystems

May 14, 2020

It is essential for healthcare ecosystem stakeholders across APAC to leverage opportunities that have arisen and prepare for the new norm.

Organization & Performance

Published Articles

How Not If: Remote Working and the ‘Next Normal’

May 18, 2020

In this article we review a range of potential remote working operating models and summarise our analytical framework for quantifying and assessing how…

Life Sciences & Pharma

Executive Insights

Precision Medicine: Accelerating “Asia for Asia” Therapeutic Solutions Market Growth

August 21, 2019

Globally, there is a tremendous amount of precision medicine research underway to develop clinical therapeutics that are more targeted in their action and…

Life Sciences & Pharma

Published Articles

After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid…

June 17, 2020

After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth.

Organization & Performance

Published Articles

Workers’ desire to work from home grows as lockdown continues

May 22, 2020

New survey shows even more people than in April (now 60%) want to commute less after the COVID crisis, as new working practices become normal.

MedTech

Special Report

Japan 2019-2020 Hospital Insights Survey

April 22, 2020

Japanese hospital operations are shifting as a result of broader financial challenges to the country’s healthcare system.